Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
320.95
-9.64 (-2.92%)
Mar 3, 2026, 12:11 PM EST - Market open
PRAX Market Cap
PRAX has a market cap or net worth of $8.94 billion as of March 3, 2026. Its market cap has increased by 435.86% in one year.
Market Cap
8.94B
Enterprise Value
7.89B
1-Year Change
435.86%
Ranking
Category
Stock Price
$320.95
Market Cap Chart
Since the IPO on October 16, 2020, PRAX's market cap has increased from $698.02M to $8.94B, an increase of 1,180.58%. That is a compound annual growth rate of 60.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 9.21B | 24.92% |
| Dec 31, 2025 | 7.37B | 397.55% |
| Dec 31, 2024 | 1.48B | 675.84% |
| Dec 29, 2023 | 190.94M | 70.27% |
| Dec 30, 2022 | 112.14M | -87.31% |
| Dec 31, 2021 | 883.49M | -58.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmunityBio | 10.73B |
| Exelixis | 10.66B |
| Madrigal Pharmaceuticals | 9.99B |
| ABIVAX Société Anonyme | 9.05B |
| Bio-Techne | 9.05B |
| Arrowhead Pharmaceuticals | 9.01B |
| Vaxcyte | 8.92B |
| Axsome Therapeutics | 8.51B |